90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate
Age
8–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
children with migraine -
You may not be if
those who suffer from ischemic heart disease , or who have allergy to any of drugs used